140 related articles for article (PubMed ID: 38829950)
1. Metabolic dysfunction-associated steatotic liver disease related cirrhosis and incidence of portal vein thrombosis.
Amjad W; Jiang ZG; Lai M
Eur J Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38829950
[TBL] [Abstract][Full Text] [Related]
2. Statin use in cirrhosis and its association with incidence of portal vein thrombosis.
Amjad W; Jiang Z; Lai M
J Gastroenterol Hepatol; 2024 May; 39(5):955-963. PubMed ID: 38273643
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study.
Chen Z; Ran T; Cao H; Xu F; Zhou ZH; He S
Front Med (Lausanne); 2021; 8():685944. PubMed ID: 34262917
[No Abstract] [Full Text] [Related]
4. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
[TBL] [Abstract][Full Text] [Related]
5. Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study.
Noronha Ferreira C; Marinho RT; Cortez-Pinto H; Ferreira P; Dias MS; Vasconcelos M; Alexandrino P; Serejo F; Pedro AJ; Gonçalves A; Palma S; Leite I; Reis D; Damião F; Valente A; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
Liver Int; 2019 Aug; 39(8):1459-1467. PubMed ID: 31021512
[TBL] [Abstract][Full Text] [Related]
6. Decreased portal vein velocity is predictive of the development of portal vein thrombosis: A matched case-control study.
Stine JG; Wang J; Shah PM; Argo CK; Intagliata N; Uflacker A; Caldwell SH; Northup PG
Liver Int; 2018 Jan; 38(1):94-101. PubMed ID: 28632958
[TBL] [Abstract][Full Text] [Related]
7. Portal vein thrombosis compromises the performance of MELD and MELD-Na scores in patients with cirrhosis.
Ouyang R; Li H; Tan W; Wang X; Zheng X; Huang Y; Meng Z; Gao Y; Qian Z; Liu F; Lu X; Shi Y; Shang J; Liu J; Deng G; Zheng Y; Yan H; Jiang X; Zhang Y; Qiao L; Zhou Y; Hou Y; Xiong Y; Chen J; Luo S; Gao N; Ji L; Li J; Zheng R; Ren H; Wang H; Zhong G; Li B; Chen J
J Gastroenterol Hepatol; 2023 Jan; 38(1):129-137. PubMed ID: 36345143
[TBL] [Abstract][Full Text] [Related]
8. Validation of the new nomenclature of steatotic liver disease in patients with a history of excessive alcohol intake: an analysis of data from a prospective cohort study.
Israelsen M; Torp N; Johansen S; Hansen CD; Hansen ED; Thorhauge K; Hansen JK; Villesen I; Bech K; Wernberg C; Andersen P; Lindvig KP; Tsochatzis EA; Thiele M; Rinella ME; Krag A;
Lancet Gastroenterol Hepatol; 2024 Mar; 9(3):218-228. PubMed ID: 38218202
[TBL] [Abstract][Full Text] [Related]
9. MELD-Na score may underestimate disease severity and risk of death in patients with metabolic dysfunction-associated steatotic liver disease (MASLD).
Yardeni D; Shiloh A; Lipnizkiy I; Nevo-Shor A; Abufreha N; Munteanu D; Novack V; Etzion O
Sci Rep; 2023 Dec; 13(1):22113. PubMed ID: 38092876
[TBL] [Abstract][Full Text] [Related]
10. Portal vein thrombosis is not associated with increased mortality among patients with cirrhosis.
Berry K; Taylor J; Liou IW; Ioannou GN
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):585-93. PubMed ID: 25459555
[TBL] [Abstract][Full Text] [Related]
11. Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event.
Balcar L; Tonon M; Semmler G; Calvino V; Hartl L; Incicco S; Jachs M; Bauer D; Hofer BS; Gambino CG; Accetta A; Brocca A; Trauner M; Mandorfer M; Piano S; Reiberger T;
JHEP Rep; 2022 Aug; 4(8):100513. PubMed ID: 35845294
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis.
Pan J; Wang L; Gao F; An Y; Yin Y; Guo X; Nery FG; Yoshida EM; Qi X
Eur J Intern Med; 2022 Oct; 104():21-32. PubMed ID: 35688747
[TBL] [Abstract][Full Text] [Related]
13. Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD.
Paternostro R; Kwanten WJ; Hofer BS; Semmler G; Bagdadi A; Luzko I; Hernández-Gea V; Graupera I; García-Pagán JC; Saltini D; Indulti F; Schepis F; Moga L; Rautou PE; Llop E; Téllez L; Albillos A; Fortea JI; Puente A; Tosetti G; Primignani M; Zipprich A; Vuille-Lessard E; Berzigotti A; Taru MG; Taru V; Procopet B; Jansen C; Praktiknjo M; Gu W; Trebicka J; Ibanez-Samaniego L; Bañares R; Rivera-Esteban J; Pericas JM; Genesca J; Alvarado E; Villanueva C; Larrue H; Bureau C; Laleman W; Ardevol A; Masnou H; Vanwolleghem T; Trauner M; Mandorfer M; Francque S; Reiberger T;
J Hepatol; 2024 May; ():. PubMed ID: 38823501
[TBL] [Abstract][Full Text] [Related]
14. Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis.
Dallio M; Romeo M; Vaia P; Auletta S; Mammone S; Cipullo M; Sapio L; Ragone A; Niosi M; Naviglio S; Federico A
World J Gastroenterol; 2024 Feb; 30(7):685-704. PubMed ID: 38515952
[TBL] [Abstract][Full Text] [Related]
15. Portal vein thrombosis risk factors in liver transplant candidates.
Ak C; Adali G; Sayar S; Agackiran A; Kulali F; Kahraman R; Ozturk O; Ozdil K
Hepatol Forum; 2022 Sep; 3(3):88-92. PubMed ID: 36177096
[TBL] [Abstract][Full Text] [Related]
16. Portal vein thrombosis and survival in patients with cirrhosis.
Englesbe MJ; Kubus J; Muhammad W; Sonnenday CJ; Welling T; Punch JD; Lynch RJ; Marrero JA; Pelletier SJ
Liver Transpl; 2010 Jan; 16(1):83-90. PubMed ID: 20035521
[TBL] [Abstract][Full Text] [Related]
17. Presence of Hepatocellular Carcinoma Does Not Affect Course and Response to Anticoagulation of Bland Portal Vein Thrombosis in Cirrhotic Patients.
Benevento F; Pecorelli A; Stefanescu H; Sparchez Z; Vukotic R; Pettinari I; Grigoras CA; Tovoli F; Ravaioli F; Stefanini B; Andreone P; Piscaglia F
J Hepatocell Carcinoma; 2023; 10():473-482. PubMed ID: 37007210
[TBL] [Abstract][Full Text] [Related]
18. Predictors of portal vein thrombosis after splenectomy in patients with cirrhosis.
Li T; Wang LL; Li YP; Gan J; Wei XS; Mao XR; Li JF
World J Hepatol; 2024 Feb; 16(2):241-250. PubMed ID: 38495270
[TBL] [Abstract][Full Text] [Related]
19. Associations of coagulation factor V Leiden and prothrombin G20210A mutations with Budd-Chiari syndrome and portal vein thrombosis: a systematic review and meta-analysis.
Qi X; Ren W; De Stefano V; Fan D
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1801-12.e7. PubMed ID: 24793031
[TBL] [Abstract][Full Text] [Related]
20. High-density lipoprotein cholesterol for the prediction of mortality in cirrhosis with portal vein thrombosis: a retrospective study.
Gao B; Xiao J; Zhang M; Zhang F; Zhang W; Yang J; He J; Liu Y; Zou X; Xu P; Zhuge Y
Lipids Health Dis; 2019 Mar; 18(1):79. PubMed ID: 30927926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
